Even as weight-loss drugs such as Wegovy and Zepbound explode in popularity, many Americans struggle to afford them.

State measures now seek to remove barriers to weight-loss drugs, as demand for the meds skyrockets amid rising concerns about ...

Self-stigma was associated with higher dropout rates, engagement, and weight loss among individuals who completed a weight loss program.

The Biden administration proposed a rule for Medicare and Medicaid to cover the costs of weight-loss drugs for millions of ...

Weight loss drugs like Ozempic have become a popular option for helping people who struggle to lose weight, but they could ...

Millions of obese Americans would get access to popular weekly injectables that would help them shed pounds quickly if a $35 ...

WASHINGTON — The Biden administration announced last Tuesday it’s reinterpreting federal law to allow Medicare and Medicaid patients access to anti-obesity medications to reduce their weight over the ...

In 2020, West Virginia launched a pilot program to subsidize GLP-1 drugs for public employees, but the program was shuttered ...

The Biden administration wants to expand coverage of anti-obesity medications to millions on Medicare, Medicaid.

While recent advances in medicine have created prescription anti-obesity GLP-1 medications — like Ozempic, Wegovy, and ...

The outgoing Biden administration is proposing to have popular weight-loss drugs like Wegovy or Zepbound covered by Medicare ...